AGIO 10-Q: SEC filing
Agios Pharmaceuticals
Filed with the SEC on · accession 0001439222-26-000131
AGIO filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Agios Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
Key details
How AGIO stock reacted
Close before
$31.38
Nov 4, 2026
First close after
-9.91%
$28.27
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AGIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AGIO?
Click hereFrequently asked questions
What did AGIO file with the SEC on Nov 5, 2026?
AGIO filed a 10-Q (SEC filing). Agios Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did AGIO stock react to this filing?
AGIO closed at $31.38 before the filing and $28.27 on Nov 5, 2026 (-9.91%).
Other AGIO SEC filings
Get alerts when AGIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days